Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 55 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 10064914

    Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival

    The Regents of the University of California · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  2. US 10058572

    Placenta-derived multipotent stem cells

    The Regents of the University of California · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  3. US 10058561

    Methods and related compositions for reduction of fat and skin tightening

    The Regents of the University of California · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  4. US 10053494

    Chemically activated nanocapsid functionalized for cancer targeting

    The Regents of the University of California · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  5. US 10047396

    Biomarkers for diagnosis of transient ischemic attacks

    The Regents of the University of California · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  6. US 10046057

    Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy

    The Regents of the University of California · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  7. US 10046016

    Mutant adeno-associated virus virions and methods of use thereof

    The Regents of the University of California · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  8. US 10039807

    bFGF-polymer conjugates, methods for making the same and applications thereof

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  9. US 10041041

    Compositions and methods for treating retinal diseases

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  10. US 10041936

    Neuronal cells cultured on microparticles and methods of using same

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  11. US 10039816

    Siderophore-based immunization against gram-negative bacteria

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  12. US 10039725

    Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

    The Regents of the University of California · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  13. US 10035981

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  14. US 10035823

    Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  15. US 10034929

    RNA interference functions as an antiviral immunity in mammals

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  16. US 10029017

    Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug

    The Regents of the University of California · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  17. US 10028983

    Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life

    The Regents of the University of California · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  18. US 10028936

    Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone

    The Regents of the University of California · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  19. US 10023588

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  20. US 10023581

    Modified cytotoxins and their therapeutic use

    The Regents of the University of California · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  21. US 10022450

    Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

    The Regents of the University of California · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  22. US 10017551

    Peptides having reduced toxicity that stimulate cholesterol efflux

    The Regents of the University of California · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  23. US 10016498

    D-amino acid derivative-modified peptidoglycan and methods of use thereof

    The Regents of the University of California · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  24. US 10016490

    Multiple-enzyme nanocomplexes

    The Regents of the University of California · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.